跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ENHERTU 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ENHERTU 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
ENHERTU 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Daiichi Sankyo Europe Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 28, 2024
Approval ID
686b222fb6d18e19
Company
Daiichi Sankyo Europe Gmbh
Type
Standard
Approval Details
Approval Id
686b222fb6d18e19
Drug Cima Aemps Name
ENHERTU 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1201508001IP
Holder Company Name
Daiichi Sankyo Europe Gmbh
Marketing Company Name
Abacus Medicine A/S
Holder Company Detail Path
/organization/daiichi-sankyo-europe-gmbh
Authorization Date
2024-10-28
Dosage Form
POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
100 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Daiichi Sankyo Europe Gmbh
Company Detail Path
/organization/daiichi-sankyo-europe-gmbh
Company Information
Pharmaceutical Company Name
Daiichi Sankyo Europe GmbH
Country Name
Germany
City Name
münchen,bayern,country_de
Address
Zielstattstr. 48
Website
http://www.daiichi-sankyo.eu
Active Ingredients
TRASTUZUMAB DERUXTECAN
107 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 28, 2024
Approval ID
686b222fb6d18e19
Type
Standard
Back to CIMA-AEMPS Approvals